ASYMX | NRGSX | ASYMX / NRGSX | |
Total Expense Ratio | 0.89 | 0.74 | 120% |
Annual Report Gross Expense Ratio | 0.96 | 0.74 | 130% |
Fund Existence | 8 years | 13 years | - |
Gain YTD | -1.615 | -2.693 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 327M | 8.71B | 4% |
Annual Yield % from dividends | 0.00 | 0.06 | - |
Returns for 1 year | 0.62 | -8.42 | -7% |
Returns for 3 years | 26.58 | 9.23 | 288% |
Returns for 5 years | -23.05 | -0.60 | 3,834% |
Returns for 10 years | N/A | 10.18 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMCUX | 17.04 | 0.27 | +1.61% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
SAGWX | 6.43 | 0.10 | +1.58% |
Touchstone Small Company A | |||
JFNAX | 74.40 | 0.65 | +0.88% |
Janus Henderson Global Life Sciences A | |||
SGQCX | 43.33 | 0.37 | +0.86% |
DWS International Growth C | |||
ABALX | 39.28 | 0.26 | +0.67% |
American Funds American Balanced A |